Macrophages and prognosis of oral squamous cell carcinoma: A systematic review

Oral Squamous Cell Carcinoma ( OSCC ) presents a tumor microenvironment rich in inflammatory cells. Depending on the stimulus, macrophages can polarize in M1 or M2 profile, where M1 acts as proinflammatory and antitumor, and M2 is anti‐inflammatory and shows protumor activity. Several studies have shown that macrophages are important to the prognosis of patients with different types of cancer. Our aim was to conduct a systematic review to evaluate the role of macrophages in the prognosis of OSCC patients. A search in the Pubmed, Scopus, and ISI Web of Knowledge database was performed, and it was included only studies that evaluated the importance of macrophages in the prognosis of OSCC patients. From initial 286 articles, 14 fully attended the inclusion criteria. In the majority of the articles, it was evaluated only CD 68, a panmacrophage marker, or CD 163, a M2 marker. Only one article evaluated the M1 marker, CD 11c. Besides, 5 articles analyzed the presence of macrophages in different areas of the tumor. Higher concentrations of CD 68 and CD 163 were associated with worse survival. In conclusion, macrophages are important to OSCC patients’ prognosis; however, it is necessary to address in which tumor region the presence of polarized macrophage is more important to the outcome.